Abbott Laboratories Q1 Revenue Surges 30% As Medical Devices Lead

Abbott Laboratories early Wednesday posted much better than expected first quarter earnings results, led by huge growth in its medical devices unit that was bolstered by a recent acquisition.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.